Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease

Study Identifier
H25-878
CT.gov Identifier
NCT06937034
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Recruiting
Sign up for trial alerts

Study Details

Medical Condition
  • Parkinson's Disease
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    Inclusion Criteria: \- Diagnosed with levodopa-responsive idiopathic Parkinson's Disease prescribed on LDp/CDp CSCI in routine clinical practice who have consented to be enrolled in the AbbVie Patient Support Program.

    Protocol Summary

    Main objective of this study is to describe the evolution of infusion settings (base, high and low infusion rates) of foslevodopa/foscarbidopa subcutaneous infusion (LDp/CDp) at different timepoints in the treatment of advanced Parkinson's disease (aPD) as captured in ONE-CRM.

    Study Locations

    Location
    Status
    Location
    Medizinische Universitaet Graz /ID# 278569
    Graz, Styria, Austria, 8010
    Status
    Not yet recruiting
    Location
    Medisch Spectrum Twente /ID# 276695
    Enschede, Overijssel, Netherlands, 7512 KZ
    Status
    Recruiting
    Location
    Universitatea De Medicină Și Farmacie Victor Babeș /ID# 276720
    Timișoara, Timiș County, Romania, 300041
    Status
    Recruiting
    Location
    Karolinska University Hospital Solna /ID# 277116
    Solna, Stockholm County, Sweden, 171 64
    Status
    Recruiting